Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Real world outcome of nodal T cell non-Hodgkin lymphoma from hematology cancer consortium registry in India

View Full Paper
Ask AI
Bookmark
Share

Authors

LNLingaraj NayakMAMithun AbrahamPKParathan Karunakaran

Discussion

Loading...

Member takes

Overview

Observational analysis revealed poor outcomes in nodal T cell lymphoma patients in India, suggesting limited efficacy of current therapies.

Key Points

  • Complete response to initial therapy was achieved in 68% of nodal T cell lymphoma patients in the registry.
  • Major toxicity observed included febrile neutropenia, affecting 35% of patients during treatment.
  • Assessment of the International Prognostic Index indicated that high scores predict unfavorable outcomes consistently.
  • Implications highlight significant challenges in treatment and follow-up due to high rates of patient drop-off in a real-world setting.

Cite This Study

Nayak et al. (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d738https://doi.org/10.1182/blood-2025-7154
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early-stage nodular lymphocyte predominant Hodgkin lymphoma: Disease characteristics, treatment pattern, and long-term outcomes from a tertiary care cancer institute in India2025
  2. 2Comparable outcomes after autologous hematopoietic cell transplantation in T-cell lymphoma regardless of pre-transplant response: A key finding in resource-limited countries.2025
  3. 3Treatment practices and outcomes of advanced stage classical Hodgkin lymphoma in India: An analysis from the hematology cancer consortium2025
  4. 4Patient characteristics, treatment patterns, and outcomes in primary CNS lymphoma of T-cell origin: A multi-institution retrospective analysis2025
  5. 5Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of Korea2025 · 1 citations